GL1X · GenesisL1 explorer

Research workbench

Vaccine-elicited nhp fp-targeting HIV neutralizing antibody dfph-A.15 in complex with HIV fusion peptide (residue 512-519)

Analyse Vaccine-elicited nhp fp-targeting HIV neutralizing antibody dfph-A.15 in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6MQE
Type
protein
Length
888 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DFPHA.15 antibody Fab light chain; DFPHA.15 antibody Fab heavy chain; HIV fusion peptide
Pockets
12 · best druggability 0.75

Structure

x-ray diffraction · 3 distinct chains · 7% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
B, LDFPHA.15 antibody Fab light chainprotein2127% helix, 51% strand—
A, HDFPHA.15 antibody Fab heavy chainprotein2247% helix, 50% strand—
C, DHIV fusion peptideprotein80% helix, 38% strand—

Pockets

12 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17290.750.8080empty
22620.610.8038empty
31630.610.8436empty
4740.600.9026empty
51640.540.8037empty

Interfaces

11 interfaces between chains.

  • B–A · 1739 Ų buried · 13 hydrogen bonds · protein-protein
  • H–L · 1667 Ų buried · 18 hydrogen bonds · protein-protein
  • A–D · 592 Ų buried · 13 hydrogen bonds · protein-protein
  • H–C · 585 Ų buried · 12 hydrogen bonds · protein-protein
  • B–L · 584 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 6MQE · Vaccine-elicited NHP FP-targeting HIV neutralizing antibody DFPH-a.15 in complex with HIV… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.